We are excited to continue delivering promising results with our drug, INT230-6.
Intensity Therapeutics, Inc.
Pharmaceutical Manufacturing
Westport, CT 1,039 followers
A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies.
About us
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases. Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
- Website
-
http://www.intensitytherapeutics.com
External link for Intensity Therapeutics, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Westport, CT
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, and Health and Medicine
Locations
-
Primary
Get directions
61 Wilton Road, 3rd Floor
Westport, CT 06880, US